Business Models and Strategy

 

Interview: Duncan Leggat, Cymphony

Cymphony is a UK company that provides customer communications solutions such as telephone answering and appointment booking to private healthcare providers. In an interview with HBI, Duncan Leggat, Cymphony’s Finance Director, argued that high quality, personalised customer service is an essential part of a good healthcare service, and that, for providers focused on the premium/private-pay part of the market, the good old fashioned telephone is generally the most effective tool for achieving this.
August 8, 2024

Transform’s journey from cosmetic surgery to weight loss services company — an interview with CEO Dr. Sayani Sainudeen

UK cosmetic surgery company Transform Healthcare has gone through quite a journey in the past 15 years. In an interview with HBI, Dr. Sayani Sainudeen, Transform's new CEO, explained how the company is moving increasingly into holistic weight loss services, covering a broad range of treatments, from new injectable weight loss drugs, to surgery, to talking therapy.
July 30, 2024

What innovations are health tech investors most excited about in 2024?

Healthcare is a sector in which it can be hard to innovate. Regulations are tight and risk aversion is rife. This is understandable — justifiable, even — given lives are at stake. But it means the sector doesn’t see much creative destruction in the models it uses for delivering care. 
July 19, 2024

PMI’s changing business model

Access to primary care is now the number one reason people in the UK want private medical insurance (PMI), according to data collected by UK health insurer Vitality. Other NHS countries have been seeing similar trends since Covid. Katie Tryon, Vitality’s Director of Health Strategy, spoke about how this has completely changed the PMI business model — for the better — at HBI’s conference last month.
July 3, 2024

Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024

The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033. This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics. At HBI 2024, the panel 'Laboratory Diagnostics – Growth Beyond Consolidation' brought together industry experts.
July 3, 2024

Veterinary fundamentals as strong as human healthcare, with more consolidation opportunities and less regulatory risk

Speakers at HBI’s first ever panel on the veterinary sector made a compelling case for the sector’s investability to HBI 2024 attendees. Demand is resilient and growing, supported by a growing number of pets as well as greater expenditure from pet owners as the range of services expands. Demand growth is also supported by greater price flexibility than human healthcare typically has in most European countries. And almost all the continent’s markets remain unconsolidated. 
June 26, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us